215 related articles for article (PubMed ID: 8391738)
1. Towards vaccines against human papillomavirus type-16 genital infections.
Cason J; Khan SA; Best JM
Vaccine; 1993; 11(6):603-11. PubMed ID: 8391738
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer, human papillomavirus and vaccines.
Khan SA
Clin Oncol (R Coll Radiol); 1993; 5(6):386-90. PubMed ID: 8305362
[TBL] [Abstract][Full Text] [Related]
3. Progress in prophylactic and therapeutic vaccines for human papillomavirus infection.
Stanley MA
Expert Rev Vaccines; 2003 Jun; 2(3):381-9. PubMed ID: 12903803
[TBL] [Abstract][Full Text] [Related]
4. Human papillomavirus genotype 16 vaccines for cervical cancer prophylaxis and treatment.
Cornelison TL
Curr Opin Oncol; 2000 Sep; 12(5):466-73. PubMed ID: 10975555
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of protein and adjuvant vaccinations on tumour growth.
Gérard CM; Baudson N; Kraemer K; Bruck C; Garçon N; Paterson Y; Pan ZK; Pardoll D
Vaccine; 2001 Mar; 19(17-19):2583-9. PubMed ID: 11257396
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines.
Stanley MA
Curr Opin Mol Ther; 2002 Feb; 4(1):15-22. PubMed ID: 11883690
[TBL] [Abstract][Full Text] [Related]
7. Immune response to genital papillomavirus infections in women. Prospects for the development of a vaccine against cervical cancer.
Gissmann L; Jochmus I; Nindl I; Müller M
Ann N Y Acad Sci; 1993 Aug; 690():80-5. PubMed ID: 8396380
[No Abstract] [Full Text] [Related]
8. Safety and immunogenicity of TA-HPV, a recombinant vaccinia virus expressing modified human papillomavirus (HPV)-16 and HPV-18 E6 and E7 genes, in women with progressive cervical cancer.
Kaufmann AM; Stern PL; Rankin EM; Sommer H; Nuessler V; Schneider A; Adams M; Onon TS; Bauknecht T; Wagner U; Kroon K; Hickling J; Boswell CM; Stacey SN; Kitchener HC; Gillard J; Wanders J; Roberts JS; Zwierzina H
Clin Cancer Res; 2002 Dec; 8(12):3676-85. PubMed ID: 12473576
[TBL] [Abstract][Full Text] [Related]
9. Serological response to HPV 16 in cervical dysplasia and neoplasia: correlation of antibodies to E6 with cervical cancer.
Ghosh AK; Smith NK; Stacey SN; Glew SS; Connor ME; Arrand JR; Stern PL
Int J Cancer; 1993 Feb; 53(4):591-6. PubMed ID: 8382193
[TBL] [Abstract][Full Text] [Related]
10. Clinical studies of human papilloma vaccines in cervical cancer.
Adams M; Borysiewicz L; Fiander A; Man S; Jasani B; Navabi H; Evans AS; Mason M
Adv Exp Med Biol; 2001; 495():419-27. PubMed ID: 11774604
[No Abstract] [Full Text] [Related]
11. Overview of vaccinology with special reference to papillomavirus vaccines.
Hilleman MR
J Clin Virol; 2000 Oct; 19(1-2):79-90. PubMed ID: 11091151
[TBL] [Abstract][Full Text] [Related]
12. Specificity of human cytotoxic T lymphocytes induced by a human papillomavirus type 16 E7-derived peptide.
Jochmus I; Osen W; Altmann A; Buck G; Hofmann B; Schneider A; Gissmann L; Rammensee HG
J Gen Virol; 1997 Jul; 78 ( Pt 7)():1689-95. PubMed ID: 9225046
[TBL] [Abstract][Full Text] [Related]
13. Papillomavirus vaccines in clinical trials.
Galloway DA
Lancet Infect Dis; 2003 Aug; 3(8):469-75. PubMed ID: 12901889
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy of a human papillomavirus (HPV) type 16 E7-expressing tumour by administration of fusion protein comprising Mycobacterium bovis bacille Calmette-Guérin (BCG) hsp65 and HPV16 E7.
Chu NR; Wu HB; Wu T; Boux LJ; Siegel MI; Mizzen LA
Clin Exp Immunol; 2000 Aug; 121(2):216-25. PubMed ID: 10931134
[TBL] [Abstract][Full Text] [Related]
15. Boosting with recombinant vaccinia increases HPV-16 E7-specific T cell precursor frequencies of HPV-16 E7-expressing DNA vaccines.
Chen CH; Wang TL; Hung CF; Pardoll DM; Wu TC
Vaccine; 2000 Apr; 18(19):2015-22. PubMed ID: 10706963
[TBL] [Abstract][Full Text] [Related]
16. A recombinant vaccinia virus encoding human papillomavirus types 16 and 18, E6 and E7 proteins as immunotherapy for cervical cancer.
Borysiewicz LK; Fiander A; Nimako M; Man S; Wilkinson GW; Westmoreland D; Evans AS; Adams M; Stacey SN; Boursnell ME; Rutherford E; Hickling JK; Inglis SC
Lancet; 1996 Jun; 347(9014):1523-7. PubMed ID: 8684105
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of vaccination against HPV infections in cervix carcinoma].
Gissmann L
Zentralbl Gynakol; 2001 May; 123(5):299-301. PubMed ID: 11449623
[TBL] [Abstract][Full Text] [Related]
18. Recombinant adeno-associated virus expressing human papillomavirus type 16 E7 peptide DNA fused with heat shock protein DNA as a potential vaccine for cervical cancer.
Liu DW; Tsao YP; Kung JT; Ding YA; Sytwu HK; Xiao X; Chen SL
J Virol; 2000 Mar; 74(6):2888-94. PubMed ID: 10684306
[TBL] [Abstract][Full Text] [Related]
19. Papillomavirus-like particles for serology and vaccine development.
Kirnbauer R
Intervirology; 1996; 39(1-2):54-61. PubMed ID: 8957670
[TBL] [Abstract][Full Text] [Related]
20. A novel mucosal vaccine based on live Lactococci expressing E7 antigen and IL-12 induces systemic and mucosal immune responses and protects mice against human papillomavirus type 16-induced tumors.
Bermúdez-Humarán LG; Cortes-Perez NG; Lefèvre F; Guimarães V; Rabot S; Alcocer-Gonzalez JM; Gratadoux JJ; Rodriguez-Padilla C; Tamez-Guerra RS; Corthier G; Gruss A; Langella P
J Immunol; 2005 Dec; 175(11):7297-302. PubMed ID: 16301635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]